Castellum, Inc. Announces Signing of Non-Binding LOI for East Coast Government Contractor
January 18, 2023 09:00 ET | Castellum, Inc.
BETHESDA, Md., Jan. 18, 2023 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM), a cybersecurity, electronic warfare, data analytics, software, and IT services company focused on the federal...
Castellum, Inc. Announces Alan R. Lynn to Join Advisory Board
January 13, 2023 06:55 ET | Castellum, Inc.
POTOMAC, Md., Jan. 13, 2023 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE American: CTM) announces Alan “Al” Lynn has joined the Company’s Advisory Board. Castellum’s Advisory Board seats experienced...
Featured Image for Hoverfly Technologies, Inc.
Hoverfly Technologies Secures Landing Ring Design Patent
January 04, 2023 11:00 ET | Hoverfly Technologies, Inc.
SANFORD, Fla., Jan. 04, 2023 (GLOBE NEWSWIRE) -- Hoverfly Technologies Inc. announced today that it has been issued U.S. Patent No. 11,518,542 from the U.S. Patent Office for the "Landing Structure...
Castellum Announces That It Is One Of The Winners Of The $900 Million Air Force Architecture And Integration Directorate Multiple Award Indefinite Delivery/Indefinite Quantity Contract (AFLCMC/XA) (MAC IDIQ)
December 12, 2022 06:55 ET | Castellum, Inc.
POTOMAC, Md., Dec. 12, 2022 (GLOBE NEWSWIRE) -- Castellum, Inc. (NYSE-American: CTM) is pleased to announce that it is one of the winners of the Architecture and Integration Directorate Multiple...
Kane Logo Cropped TransBG.png
Kane Biotech Receives an Additional $425K USD of Funding for its DispersinB® Hydrogel from the United States Department of Defense
October 04, 2022 08:00 ET | Kane Biotech Inc.
WINNIPEG, Manitoba, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it has received an additional $425,000 USD of...
IMC Logo.jpg
Immuron new MTEC project proposal “Development of Oral Immunotherapy for the Prevention of Bacterial Diarrheal Disease”
April 19, 2022 07:33 ET | Immuron Limited
Key Highlights: Immuron’s request for AU$5.4M (US$4M) additional funding from the U.S. Department of Defense for Travelan considered to be ‘eligible for award’Travelan Investigational New Drug (IND)...
Castellum, Inc. Announces $950,000 New Revolving Credit Facility from Live Oak Bank
April 04, 2022 09:00 ET | Castellum, Inc.
POTOMAC, Md., April 04, 2022 (GLOBE NEWSWIRE) -- Castellum, Inc. (OTC: ONOV) announces that it has secured a new $950,000 revolving accounts receivable-based credit facility from Live Oak Bank. "We...
Castellum Announces Signing Definitive Agreement to Acquire Lexington Solutions Group 
February 25, 2022 09:00 ET | Castellum, Inc.
POTOMAC, Md., Feb. 25, 2022 (GLOBE NEWSWIRE) -- Castellum, Inc. (OTC: ONOV) announces the signing of a “Definitive Purchase Agreement” to acquire Lexington Solutions Group (“LSG”), a $4 million...
Castellum, Inc. Announces Appointment of Former Congressman and NBA Player Tom McMillen to Company's Advisory Board
February 03, 2022 09:00 ET | Castellum, Inc.
POTOMAC, Md., Feb. 03, 2022 (GLOBE NEWSWIRE) -- Castellum, Inc. (OTC: ONOV) proudly announces that former Congressman, NBA player, Olympian, and Rhodes Scholar Tom McMillen joined the Company's...
Castellum, Inc. Announces Q4 Record Revenue
January 27, 2022 09:00 ET | Castellum, Inc.
POTOMAC, Md., Jan. 27, 2022 (GLOBE NEWSWIRE) --  Castellum, Inc. (OTC: ONOV) announces that it generated approximately $9.5 million in unaudited revenue in the fourth quarter ended December 31,...